Source: International Congress 2018 – Asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mogrovejo Calle (Valencia, Spain), E. Martínez Moragón (Valencia, Spain), J. Delgado Romero (Sevilla, Spain), A. Levy Naon (Ceuta, Spain), F. González Barcala (Ceuta, Spain), V. Serrano Gutiérrez (León, Spain), A. Moreno Fernández (Madrid, Spain). Step-down of moderate-severe asthma treatment in clinical practice. 1686

Member's Comments

No comment yet.

Related content which might interest you: Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Implementation of questionnaires in the management of asthma patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013 Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting Source: International Congress 2017 – Asthma management Year: 2017 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Efficacy of the using budesonide/formoterol in patients with bronchial asthma (BA): the study of routine clinical practice Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 The management of mild asthma Source: Eur Respir J, 57 (4) 2003051; 10.1183/13993003.03051-2020 Year: 2021 Sputum assessment in asthma management does not improve disease control when GINA step-up treatment is used in mild-to-moderate patients Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Efficacy of a comprehensive education program including inhaler training and COPD management during hospitalization of AECOPD, a randomized controlled clinical Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 Implementation of questionnaires in the management of COPD patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013 Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma Source: Eur Respir J, 55 (5) 1902259; 10.1183/13993003.02259-2019 Year: 2020 Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 COPD management in Swedish clinical practice Source: Annual Congress 2007 - Primary care management of COPD Year: 2007 Effectiveness of rehabilitation in patients with asthma Source: Annual Congress 2008 - Models of pulmonary rehabilitation in non-COPD patients Year: 2008 Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016